Mirae Asset Global Investments Co., Ltd. Xeris Biopharma Holdings, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,968 shares of XERS stock, worth $29,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,968
Previous 5,389
7.81%
Holding current value
$29,559
Previous $15,000
6.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
162Shares Held
61MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$61.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$47 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$19.9 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$19.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$17.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $809M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...